M&A / Deals Bayer banks 3bn in Apollo contraceptives division deal Pharmaceutical TechnologyBayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.Read full story pharminent July 10, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology Bayer’s agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilarNext: GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China Related Stories M&A / Deals Spero snaps up Innovent immunology drug in strategic pivot pharminent July 14, 2026 M&A / Deals AstraZeneca takes another China trip, picking Dizal’s lung cancer drug for up to $1.5B pharminent July 14, 2026 M&A / Deals Novartis and Chai Discovery collaborate on antibody identification pharminent July 14, 2026
